Untitled Document
Expert PracticeSM in Breast Cancer
7 February 2009 | Berlin, Germany

Meeting Information

On behalf of Dr Nadia Harbeck, meeting chairman, we are pleased to invite you to the Expert PracticeSM in Breast Cancer meeting in
Berlin, Germany, on 7 February 2009.

During this case-based meeting, leaders in the field discuss clinical issues encountered daily with participants in an interactive format.


Delegates will receive:
  • Round trip economy air or train transportation.
  • Hotel accommodation for 6 February. If no return flight available after the meeting, hotel accommodation will also be provided Saturday, 7 February.

Faculty

Chair:
          Nadia Harbeck, MD, PhD – Germany
Speakers:
          Ahmad Awada, MD, PhD – Belgium
          Jacques Bonneterre, MD, PhD – France
          Michael Gnant, MD, PhD – Austria
          Paolo Pronzato, MD – Italy
          Julie Doughty, MD, FRCS – United Kingdom

Agenda

Friday, 6 February 2009
20.00 Reception followed by Buffet Dinner
Saturday, 7 February 2009
08.00 Breakfast
09.00 Welcome and Introduction
Nadia Harbeck, MD, PhD, Technical University of Munich, Munich, Germany
Bojana Pajk, MD, PRIME Oncology
Lee Lokey, MD, PRIME Oncology
09.20 Case #1 HER-2 Amplified Early Breast Cancer: Choosing the Most Effective Adjuvant Therapy
Jacques Bonneterre, MD, Centre Oscar Lambret, Lille, France
09.50 Case #2 Endocrine Responsive Early Breast Cancer: Decision Making for the Postmenopausal Patient
Julie Doughty, MD, University of Glasgow, Glasgow, UK
10.20 Case #3 Targeted Therapy for HER-2 Positive Metastatic Breast Cancer
Ahmad Awada, MD, PhD, Jules Bordet Institute, Brussels, Belgium
10.50 Break
11.10 Case #4 Neoadjuvant Therapy in Endocrine Responsive HER-2 Negative Breast Cancer: Multidisciplinary Management
Julie Doughty, MD, University of Glasgow, Glasgow, UK
Paolo Pronzato, MD, S. Andrea Hospital, La Spezia, Italy
Michael Gnant, MD, Medical University of Vienna, Vienna, Austria (commentary)
11.50 Debate
In the Near Future Evidence from Randomized Clinical Trials Will Support Inclusion of Zoledronic Acid as a Component of Adjuvant Systemic Therapy for Early Breast Cancer
      Pro: Michael Gnant, MD, Medical University of Vienna, Vienna, Austria
      Contra: Paolo Pronzato, MD, S. Andrea Hospital, La Spezia, Italy
12.20  Ask the Experts: An Interactive Discussion
12.40  Lunch
13.40 Case #5 Breast Cancer Progression After Adjuvant Chemotherapy: What is the Best Approach?
Ahmad Awada, MD, PhD, Jules Bordet Institute, Brussels, Belgium
14.10 Case #6 Breast Cancer Management During Pregnancy: A Difficult Challenge
Nadia Harbeck, MD, PhD, Technical University of Munich, Munich, Germany
14.40 Ask the Experts: An Interactive Discussion
15.00 Concluding Remarks
Nadia Harbeck, MD, PhD, Technical University of Munich, Munich, Germany

Meeting Slides

Print Materials



Support

This activity is supported by an educational grant from: